Hidalgo et al., 2017 - Google Patents
Regulation of human immunodeficiency virus type 1 (HIV-1) mRNA translationHidalgo et al., 2017
- Document ID
- 5767839002674481394
- Author
- Hidalgo L
- Swanson C
- Publication year
- Publication venue
- Biochemical Society Transactions
External Links
Snippet
Human immunodeficiency virus type 1 (HIV-1) mRNA translation is a complex process that uses the host translation machinery to synthesise viral proteins. Several mechanisms for HIV- 1 mRNA translation initiation have been proposed including (1) cap-dependent, eIF4E …
- 241000713772 Human immunodeficiency virus 1 0 title abstract description 193
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hidalgo et al. | Regulation of human immunodeficiency virus type 1 (HIV-1) mRNA translation | |
| Poon et al. | Human immunodeficiency virus type 1 (HIV-1) Vpr enhances expression from unintegrated HIV-1 DNA | |
| Accola et al. | A conserved dileucine-containing motif in p6 gag governs the particle association of Vpx and Vpr of simian immunodeficiency viruses SIVmac and SIVagm | |
| Gummuluru et al. | Cell cycle-and Vpr-mediated regulation of human immunodeficiency virus type 1 expression in primary and transformed T-cell lines | |
| Khan et al. | Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA | |
| Selig et al. | Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses | |
| Zheng et al. | Human p32 protein relieves a post-transcriptional block to HIV replication in murine cells | |
| Ross et al. | Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein | |
| Berkowitz et al. | Construction and molecular analysis of gene transfer systems derived from bovine immunodeficiency virus | |
| Ong et al. | Low TRBP levels support an innate human immunodeficiency virus type 1 resistance in astrocytes by enhancing the PKR antiviral response | |
| Coyle et al. | The Tpr protein regulates export of mRNAs with retained introns that traffic through the Nxf1 pathway | |
| Liang et al. | Human T-lymphotropic virus type 1 oncoprotein tax promotes S-phase entry but blocks mitosis | |
| Kibler et al. | CREB/ATF-dependent repression of cyclin a by human T-cell leukemia virus type 1 Tax protein | |
| De Breyne et al. | Focus on translation initiation of the HIV-1 mRNAs | |
| Deforges et al. | Two ribosome recruitment sites direct multiple translation events within HIV1 Gag open reading frame | |
| de Breyne et al. | In vitro studies reveal that different modes of initiation on HIV‐1 mRNA have different levels of requirement for eukaryotic initiation factor 4F | |
| Liu et al. | Translational regulation of HIV-1 replication by HIV-1 Rev cellular cofactors Sam68, eIF5A, hRIP, and DDX3 | |
| Ohlmann et al. | Translation initiation of the HIV-1 mRNA | |
| Li et al. | The S2 gene of equine infectious anemia virus is dispensable for viral replication in vitro | |
| Carvajal et al. | Structural domains within the HIV‐1 mRNA and the ribosomal protein S25 influence cap‐independent translation initiation | |
| Clark et al. | Loss of G1/S checkpoint in human immunodeficiency virus type 1-infected cells is associated with a lack of cyclin-dependent kinase inhibitor p21/Waf1 | |
| Maunder et al. | Enhancing titres of therapeutic viral vectors using the transgene repression in vector production (TRiP) system | |
| Madison et al. | Allosteric HIV-1 integrase inhibitors lead to premature degradation of the viral RNA genome and integrase in target cells | |
| Paz et al. | SRSF1 RNA recognition motifs are strong inhibitors of HIV-1 replication | |
| Ross et al. | Human T-cell leukemia virus type 2 tax mutants that selectively abrogate NFκB or CREB/ATF activation fail to transform primary human T cells |